ATE246509T1 - Bakterien-stämme mit verändertem gallensäuren- stoffwechsel und deren verwendung - Google Patents

Bakterien-stämme mit verändertem gallensäuren- stoffwechsel und deren verwendung

Info

Publication number
ATE246509T1
ATE246509T1 AT97830040T AT97830040T ATE246509T1 AT E246509 T1 ATE246509 T1 AT E246509T1 AT 97830040 T AT97830040 T AT 97830040T AT 97830040 T AT97830040 T AT 97830040T AT E246509 T1 ATE246509 T1 AT E246509T1
Authority
AT
Austria
Prior art keywords
bile acid
acid metabolism
bacteria strains
strains
altered
Prior art date
Application number
AT97830040T
Other languages
German (de)
English (en)
Inventor
Simone Claudio De
Vesely Renata Maria Cavaliere
Original Assignee
Simone Claudio De
Vesely Marco Emilio
Vesely Leonardo
Vesely Alessandro
Vesely Sara
Vesely Marina Eva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373572&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE246509(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Simone Claudio De, Vesely Marco Emilio, Vesely Leonardo, Vesely Alessandro, Vesely Sara, Vesely Marina Eva filed Critical Simone Claudio De
Application granted granted Critical
Publication of ATE246509T1 publication Critical patent/ATE246509T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97830040T 1996-03-11 1997-02-05 Bakterien-stämme mit verändertem gallensäuren- stoffwechsel und deren verwendung ATE246509T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000468A IT1283225B1 (it) 1996-03-11 1996-03-11 Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle

Publications (1)

Publication Number Publication Date
ATE246509T1 true ATE246509T1 (de) 2003-08-15

Family

ID=11373572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97830040T ATE246509T1 (de) 1996-03-11 1997-02-05 Bakterien-stämme mit verändertem gallensäuren- stoffwechsel und deren verwendung

Country Status (13)

Country Link
US (6) US6225104B1 (US20020095090A1-20020718-M00002.png)
EP (1) EP0795604B1 (US20020095090A1-20020718-M00002.png)
JP (1) JP4057091B2 (US20020095090A1-20020718-M00002.png)
KR (1) KR100472061B1 (US20020095090A1-20020718-M00002.png)
CN (1) CN1110547C (US20020095090A1-20020718-M00002.png)
AT (1) ATE246509T1 (US20020095090A1-20020718-M00002.png)
CA (1) CA2198518C (US20020095090A1-20020718-M00002.png)
DE (1) DE69723898T2 (US20020095090A1-20020718-M00002.png)
DK (1) DK0795604T3 (US20020095090A1-20020718-M00002.png)
ES (1) ES2200145T3 (US20020095090A1-20020718-M00002.png)
IT (1) IT1283225B1 (US20020095090A1-20020718-M00002.png)
MX (1) MX9701816A (US20020095090A1-20020718-M00002.png)
PT (1) PT795604E (US20020095090A1-20020718-M00002.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US7374606B2 (en) * 2003-06-27 2008-05-20 Canon Kabushiki Kaisha Water-based ink and ink recording method
EP2336153B1 (en) * 2003-11-21 2016-03-30 Pfenex Inc. Improved expression systems with SEC-system secretion
CN1663573B (zh) * 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
CN101039685B (zh) * 2004-03-31 2010-06-16 卡尔皮斯株式会社 预防、抑制肝病的制剂和预防、抑制肝病的功能食品
KR101491867B1 (ko) * 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
EA019985B1 (ru) * 2008-03-04 2014-07-30 Диковский Александр Владимирович Фармацевтическая композиция на основе гепатопротектора и пребиотика, получение и применение
US20140086849A1 (en) 2012-09-21 2014-03-27 Elizabeth McKenna Naturally-Occurring CpG Oligonucleotide Compositions and Therapeutic Applications Thereof
WO2013109635A1 (en) 2012-01-16 2013-07-25 Elizabeth Mckenna Compositions and methods for the treatment of hepatic diseases and disorders
EP3172973B1 (en) * 2015-11-27 2020-04-08 DAFLORN Ltd. Probiotic formula, process of its preparation and use
WO2017102816A1 (en) * 2015-12-14 2017-06-22 Metabogen Ab Treatment of intrahepatic cholestasis and related liver diseases
CN115569141B (zh) * 2022-10-17 2023-10-20 中国农业科学院兰州兽医研究所 脱氧胆酸在制备抗口腔链球菌产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1221734B (it) * 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1255241B (it) * 1992-07-22 1995-10-20 Simos Contos Derivato di acido biliare e suo uso in terapia
JP2992945B2 (ja) * 1994-03-11 1999-12-20 カルピス株式会社 ラクトバチルス・アシドフィルス乳酸菌
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
TWI241912B (en) * 2002-10-30 2005-10-21 Food Industry Res & Dev Inst Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol

Also Published As

Publication number Publication date
DE69723898D1 (de) 2003-09-11
US20110217759A1 (en) 2011-09-08
CA2198518C (en) 2010-04-13
US6225104B1 (en) 2001-05-01
DK0795604T3 (da) 2003-10-27
ITMI960468A0 (US20020095090A1-20020718-M00002.png) 1996-03-11
EP0795604A2 (en) 1997-09-17
CA2198518A1 (en) 1997-09-11
KR970065708A (ko) 1997-10-13
PT795604E (pt) 2003-12-31
KR100472061B1 (ko) 2005-07-08
US7959911B2 (en) 2011-06-14
US20030082791A1 (en) 2003-05-01
JPH1086A (ja) 1998-01-06
USRE41276E1 (en) 2010-04-27
DE69723898T2 (de) 2004-01-29
US20040259227A1 (en) 2004-12-23
MX9701816A (es) 1998-04-30
JP4057091B2 (ja) 2008-03-05
EP0795604A3 (en) 1998-04-15
IT1283225B1 (it) 1998-04-16
ITMI960468A1 (it) 1997-09-11
CN1110547C (zh) 2003-06-04
US20010012629A1 (en) 2001-08-09
CN1165857A (zh) 1997-11-26
EP0795604B1 (en) 2003-08-06
ES2200145T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
ATE246509T1 (de) Bakterien-stämme mit verändertem gallensäuren- stoffwechsel und deren verwendung
TW289020B (US20020095090A1-20020718-M00002.png)
FI971033A0 (fi) Metoder foer infoerande av material i huden, samt daerfoer anvaenda kompositioner
DE69124879T2 (de) Modifizierte Polydextrose und deren Herstellung
AU6452194A (en) Pharmaceutical agents for treatment of emesis
ATE138639T1 (de) L-carnitin- und alkanoyl-l-carnitin-ester mit glykolsäure oder ihre ester und diese enthaltende pharmazeutische zusammensetzungen zur behandlung von dermatosen
ATE84029T1 (de) Substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antimikrobieller wirksamkeit.
DE69939721D1 (de) Fulvinsäure und deren Verwendung in der Behandlung von Candida Infektionen
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
ATE180968T1 (de) Polyaspartamidderivate als adsorptionsmittel für gallensäuren, mit gallensäuren beladene polyaspartamidderivate und verfahren zu deren herstellung sowie deren anwendung als arzneimittel
BR9506607A (pt) Composiçao e método para controlar o crescimento de pelo menos um microrganismo
FR2708621A1 (fr) Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation.
BR9506608A (pt) Composição e método para controlar o crescimento de pelo menos um microorganismo e método para impedir a deterioração de um produto material ou meio causada por bactérias fungos ou ambos
PL306158A1 (en) Phenyl-substituted 1,4-dihydropyridines, method of obtaining them and therapeutic agents containing such compounds
DE69009765D1 (de) Kynurensäurederivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2191671T3 (es) Esteres de 1,4-dihidropiridina 4-fenil-3-sustituidos.
AR009470A1 (es) COMPOSICIoN FARMACÉUTICA QUE CONTIENE CEPAS BACTERIANAS Y UTILES EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS CON O CAUSADAS POR ALTERACIONES EN EL METABOLISMO DE LOS ÁCIDOS BILIARES, Y USO DE LAS MISMAS.
CA2135712A1 (en) The synergistic activity of glutaraldehyde in the presence of oxidants

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0795604

Country of ref document: EP

REN Ceased due to non-payment of the annual fee